q I read with great interest the recent review of Skottun and Skoyles (2007) on contrast sensitivity and magnocellular functions in schizophrenia. The authors critically reviewed available contrast sensitivity studies and concluded that these data do not provide evidence for the existence of an association between magnocellular deficits and schizophrenia. The main criticism was related to the fact that contrast sensitivity loss is not confined to low spatial frequencies in schizophrenia. Instead, the majority of studies found generalized contrast sensitivity loss, which can be explained by attention dysfunctions. The authors also claimed that contrast sensitivity data do not indicate the overactivity of magnocellular pathways or the detrimental effect of antipsychotic medications. Although I agree with the authors that further investigations are necessary, I think that the basic conclusion of the review is not entirely correct. If we want to make conclusions about the functioning of magnocellular and parvocellular pathways in schizophrenia, it is not sufficient to focus on luminance contrast sensitivity data. Instead, a more comprehensive and integrative review of results from behavioral, electrophysiological, and brain imaging studies is necessary, as done by Butler and Javitt (2005) . These data indicate a predominant magnocellular dysfunction, with some additional deficits of the parvocellular pathways in schizophrenia. These dysfunctions are associated with structural changes of the occipital cortex and the optic radiation (Butler & Javitt, 2005) . Here, I will focus on four critical questions which are closely related to the review of Skottun and Skoyles.
First, the authors overemphasized the role of spatial frequency in the assessment of magnocellular versus parvocellular contributions to contrast sensitivity. Although there is a general consensus that magnocellular pathways are optimally activated by stimuli with low contrast and low spatial frequency, it has been shown that off-center magnocellular units display higher contrast sensitivity than parvocellular units even at 9 cycles/degree (Hicks, Lee, & Vidyasagar, 1983) . Kaplan, Purpura, and Shapley (1987) demonstrated that the transmission ratio of the lateral geniculate nucleus (geniculate response/retinal response) depend on stimulus contrast (non-linear contrast gain control) and temporal frequency. However, the attenuating effect of the lateral geniculate nucleus was less affected by the spatial frequency of the stimulus. With the integration of animal physiological and human psychophysical observations, Plainis and Murray (2000) concluded that the magnocellular system is the physiological substrate for most of the contrast sensitivity functions, with the exception of the highest spatial frequencies. Skottun and Skoyles stated that the parvocellular system carries out contrast detection above 1.5 cycles/ degree. This estimation may not be correct; magnocellular pathways may be important at higher spatial frequencies. Given the contrast gain characteristics of parvocellular pathways, low contrast gratings even at higher spatial frequencies are not optimal to isolate these pathways. Neurophysiological and lesion studies in primates suggest that chromatic stimulus properties can more optimally isolate magnocellular and parvocellular visual pathways than spatial stimulus properties alone (Lee, 1996) . This assumption is supported by human studies demonstrating that the degeneration of the magnocellular pathways in fragile X syndrome does not disrupt chromatic contrast sensitivity (Kogan et al., 2004) .
To more parsimoniously isolate magnocellular and parvocellular pathways, we used a spatial offset detection (vernier) task during which stimuli were low contrast (5%) dots, frequency-doubling gratings (25 Hz), and dots defined by hue (isoluminant color) (Kéri, Kelemen, Benedek, & Janka, 2004 . Achromatic vernier acuity may be preserved after the lesion of the parvocellular system (Lynch, Silveira, Perry, & Merigan, 1992) , and there is a strong correspondence between the electrophysiological responses of primate magnocellular ganglion cells and human psychophysical performance when low contrast vernier stimuli are used (Lee, Wehrhahn, Westheimer, & Kremers, 1995; Sun, Rüttiger, & Lee, 2004) . This is true even during foveal viewing (Wehrhahn & Westheimer, 1990) . In contrast, the isoluminant color condition biases information processing towards the parvocellular pathways.
Results from our vernier studies indicated that unmedicated and medicated schizophrenia patients as well as their biological relatives consistently showed more definitive impairments in the low contrast and frequency-doubling conditions than in the isoluminant condition which is a very likely indicator of magnocellular dysfunction. These results are not properly interpreted by Skottun and Skoyles, amalgamating these results with the contrast sensitivity data. In addition, the differential deficit found in the vernier tasks is against the possibility that early visual impairments can fully be explained by a generalized attention deficit, as claimed by Skottun and Skoyles.
Third, regarding the effect of antipsychotic medications, Skottun and Skoyles did not take into consideration the different characteristics of typical (first-generation) and atypical (second-generation) antipsychotics. Typical drugs strongly block D 2 dopamine receptors leading to ''visual Parkinsonism", whereas atypical drugs with weaker dopamine receptor inhibiting properties and additional pharmacological actions (e.g., blockade of the 5-HT 2A serotonin receptors) do not do so. Therefore, it is important to take into consideration earlier studies that were conducted before the era of atypical antipsychotics. These studies suggest a detrimental effect of antipsychotics on contrast sensitivity functions (e.g., Bulens, Meerwaldt, van der Wildt, & Keemink, 1989) . In contrast, atypical drugs do not disrupt contrast sensitivity (Chen et al., 2003) .
Fourth, when arguing against the overactivity of magnocellular pathways, Skottun and Skoyles did not take into consideration the possibility that magnocellular dysfunctions may change during the course of the illness. Recently, using a steady-and pulsed-pedestal paradigm, we showed that persons at a very early (prodromal) stage of the illness display elevated contrast sensitivity during a magnocellular test and normal sensitivity during a parvocellular test. Chen et al. (2003) also found that unmedicated schizophrenia patients show higher contrast sensitivity (lower threshold) as compared with that of the controls. The severity of visual illusions experiences by the prodromal participants positively correlated with the magnocellular sensitivity values (Kéri & Benedek, 2007) . These results suggest that the early active stage of the illness is associated with overactive magnocellular pathways, which may be responsible for the experience of abnormal intensity of environmental stimuli, feelings of being flooded and inundated, and inability to focus attention to relevant details.
In summary, the review of Skottun and Skoyles did not integrate data from new behavioral paradigms and from a number of electrophysiological and brain imaging studies which all suggest the marked impairment of magnocellular pathways in schizophrenia (Butler & Javitt, 2005) . A more balanced review and discussion would be necessary to see the real picture which may help researchers find the most critical issues for future studies.
